Our technology was developed to advance research, therapeutic development, and clinical diagnosis.
Understanding the tumor microenvironment on a patient-by-patient basis will improve immunotherapies. With our technology, researchers can better understand T-cells, immune signaling, and driver mutations within the tumor microenvironment at sub-cellular resolution.
Our initial technology was designed to advance our understanding of HIV biology. We cover a broad spectrum of immune host interactions, cell-typing, signaling and activation pathways, virus genome (RNA & DNA), and virus transcriptome all localized within the same FFPE or Fresh Frozen sample.
Creation of a comprehensive brain cell atlas will have enormous benefit to both basic neuroscience research and biomedical applications such as understanding and treating traumatic brain injury and neurodegenerative diseases.